1
15
Growth Score
-4 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1238419
The biotech company is currently developing treatments for heart
Karen Duggan: Executive Director & Chief Executive Officer & FounderPast Role: South Western Sydney Area Health Service, Director of the Hypertension Service
About the Company
From 20 years of scientific observations of metabolic change as a result of salt intake, came the discovery by Dr Karen Duggan in 2003 that a naturally occurring molecule in the human body was capable of reversing fibrosis caused by hypertension and other chronic diseases such as diabetes.
In 2005 Vectus Biosystems Limited was formed to take Dr
Duggan’s discovery through to an orally deliverable drug.
